- Exhibit & Support
- Travel & Hotels
As cardiovascular disease becomes more manageable and preventable, selecting the most appropriate therapy is key. Learn best practices on the management of cholesterol and dyslipidemia from the American College of Cardiology 2017 Expert Consensus Decision Pathway and the National Lipid Association 2017 recommendations. You will also hear from experts about the role of non-statin therapies, including PCSK9 inhibitors, in cardiovascular risk reduction.
At the completion of this application-based activity, participants will be able to: